Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma GroupAxel Le Cesne, Jaap Verweij, H.J. Keizer et al.|Journal of Clinical Oncology|2000Cited by 258
Thromboembolic Events During Chemotherapy for Germ Cell Cancer: A Cohort Study and Review of the LiteratureNir I. Weijl, Susanne Osanto, Marc F. J. Rutten et al.|Journal of Clinical Oncology|2000Cited by 223